242 related articles for article (PubMed ID: 9377554)
1. Inactivation of H19, an imprinted and putative tumor repressor gene, is a preneoplastic event during Wilms' tumorigenesis.
Cui H; Hedborg F; He L; Nordenskjöld A; Sandstedt B; Pfeifer-Ohlsson S; Ohlsson R
Cancer Res; 1997 Oct; 57(20):4469-73. PubMed ID: 9377554
[TBL] [Abstract][Full Text] [Related]
2. Role of genomic imprinting in Wilms' tumour and overgrowth disorders.
Reeve AE
Med Pediatr Oncol; 1996 Nov; 27(5):470-5. PubMed ID: 8827076
[TBL] [Abstract][Full Text] [Related]
3. Genomic imprinting and Wilms' tumor.
Moulton T; Chung WY; Yuan L; Hensle T; Waber P; Nisen P; Tycko B
Med Pediatr Oncol; 1996 Nov; 27(5):476-83. PubMed ID: 8827077
[TBL] [Abstract][Full Text] [Related]
4. Loss of imprinting of IGF2 is linked to reduced expression and abnormal methylation of H19 in Wilms' tumour.
Steenman MJ; Rainier S; Dobry CJ; Grundy P; Horon IL; Feinberg AP
Nat Genet; 1994 Jul; 7(3):433-9. PubMed ID: 7920665
[TBL] [Abstract][Full Text] [Related]
5. High incidence of loss of heterozygosity and abnormal imprinting of H19 and IGF2 genes in invasive cervical carcinomas. Uncoupling of H19 and IGF2 expression and biallelic hypomethylation of H19.
Douc-Rasy S; Barrois M; Fogel S; Ahomadegbe JC; Stéhelin D; Coll J; Riou G
Oncogene; 1996 Jan; 12(2):423-30. PubMed ID: 8570220
[TBL] [Abstract][Full Text] [Related]
6. Loss of imprinting of IGF2 sense and antisense transcripts in Wilms' tumor.
Vu TH; Chuyen NV; Li T; Hoffman AR
Cancer Res; 2003 Apr; 63(8):1900-5. PubMed ID: 12702581
[TBL] [Abstract][Full Text] [Related]
7. Altered expression of imprinted genes in Wilms tumors.
Hubertus J; Lacher M; Rottenkolber M; Müller-Höcker J; Berger M; Stehr M; von Schweinitz D; Kappler R
Oncol Rep; 2011 Mar; 25(3):817-23. PubMed ID: 21174059
[TBL] [Abstract][Full Text] [Related]
8. Mosaic allelic insulin-like growth factor 2 expression patterns reveal a link between Wilms' tumorigenesis and epigenetic heterogeneity.
Ohlsson R; Cui H; He L; Pfeifer S; Malmikumpu H; Jiang S; Feinberg AP; Hedborg F
Cancer Res; 1999 Aug; 59(16):3889-92. PubMed ID: 10463576
[TBL] [Abstract][Full Text] [Related]
9. Multipoint analysis of human chromosome 11p15/mouse distal chromosome 7: inclusion of H19/IGF2 in the minimal WT2 region, gene specificity of H19 silencing in Wilms' tumorigenesis and methylation hyper-dependence of H19 imprinting.
Dao D; Walsh CP; Yuan L; Gorelov D; Feng L; Hensle T; Nisen P; Yamashiro DJ; Bestor TH; Tycko B
Hum Mol Genet; 1999 Jul; 8(7):1337-52. PubMed ID: 10369881
[TBL] [Abstract][Full Text] [Related]
10. Expression, promoter usage and parental imprinting status of insulin-like growth factor II (IGF2) in human hepatoblastoma: uncoupling of IGF2 and H19 imprinting.
Li X; Adam G; Cui H; Sandstedt B; Ohlsson R; Ekström TJ
Oncogene; 1995 Jul; 11(2):221-9. PubMed ID: 7624139
[TBL] [Abstract][Full Text] [Related]
11. Hypervariable allelic expression patterns of the imprinted IGF2 gene in tumor cells.
He L; Cui H; Walsh C; Mattsson R; Lin W; Anneren G; Pfeifer-Ohlsson S; Ohlsson R
Oncogene; 1998 Jan; 16(1):113-9. PubMed ID: 9467950
[TBL] [Abstract][Full Text] [Related]
12. Genomic imprinting and Igf2 influence liver tumorigenesis and loss of heterozygosity in SV40 T antigen transgenic mice.
Haddad R; Held WA
Cancer Res; 1997 Oct; 57(20):4615-23. PubMed ID: 9377577
[TBL] [Abstract][Full Text] [Related]
13. H19 and Igf2 monoallelic expression is regulated in two distinct ways by a shared cis acting regulatory region upstream of H19.
Srivastava M; Hsieh S; Grinberg A; Williams-Simons L; Huang SP; Pfeifer K
Genes Dev; 2000 May; 14(10):1186-95. PubMed ID: 10817754
[TBL] [Abstract][Full Text] [Related]
14. Proinsulin-like growth factor-II overexpression does not alter monoallelic H19 gene expression in transfected human embryonic kidney fibroblasts.
Kiess W; Paquette J; Koepf G; Wolf E; Deal C
Biochem Biophys Res Commun; 1999 Feb; 255(2):226-30. PubMed ID: 10049690
[TBL] [Abstract][Full Text] [Related]
15. Regulatory mechanisms at the mouse Igf2/H19 locus.
Kaffer CR; Grinberg A; Pfeifer K
Mol Cell Biol; 2001 Dec; 21(23):8189-96. PubMed ID: 11689707
[TBL] [Abstract][Full Text] [Related]
16. Frequent loss of imprinting at the IGF2 and H19 genes in head and neck squamous carcinoma.
el-Naggar AK; Lai S; Tucker SA; Clayman GL; Goepfert H; Hong WK; Huff V
Oncogene; 1999 Nov; 18(50):7063-9. PubMed ID: 10597307
[TBL] [Abstract][Full Text] [Related]
17. Expression of H19 does not influence the timing of replication of the Igf2/H19 imprinted region.
Windham CQ; Jones PA
Dev Genet; 1997; 20(1):29-35. PubMed ID: 9094209
[TBL] [Abstract][Full Text] [Related]
18. [Wilms' tumors and malformation complexes].
Hata J; Fukuzawa R; Takata A; Kikuchi H
Nihon Rinsho; 2000 Jul; 58(7):1419-25. PubMed ID: 10921316
[TBL] [Abstract][Full Text] [Related]
19. Altered imprinting of the H19 and insulin-like growth factor II genes in testicular tumors.
Nonomura N; Miki T; Nishimura K; Kanno N; Kojima Y; Okuyama A
J Urol; 1997 May; 157(5):1977-9. PubMed ID: 9112575
[TBL] [Abstract][Full Text] [Related]
20. Genomic profiling maps loss of heterozygosity and defines the timing and stage dependence of epigenetic and genetic events in Wilms' tumors.
Yuan E; Li CM; Yamashiro DJ; Kandel J; Thaker H; Murty VV; Tycko B
Mol Cancer Res; 2005 Sep; 3(9):493-502. PubMed ID: 16179496
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
